
Given the known involvement of IL-36 in psoriasis it might be surprising that the latest mouse models show that inhibiting IL-36 signalling does not alter the course of inflammatory arthritis. Can we now add IL-36 to the list of inflammatory mediators that are not viable DMARD targets?
Inflammation, Synovitis, Arthritis, Synovial Membrane, Receptors, Interleukin-1, Dermatitis, Receptors, Interleukin, 616.07, Arthritis, Experimental, Mice, 616, Animals, Humans, Psoriasis, Interleukin-1, Skin
Inflammation, Synovitis, Arthritis, Synovial Membrane, Receptors, Interleukin-1, Dermatitis, Receptors, Interleukin, 616.07, Arthritis, Experimental, Mice, 616, Animals, Humans, Psoriasis, Interleukin-1, Skin
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 41 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
